
New Orleans — Botulinum toxin type A (Botox, Botox Cosmetic; Allergan) can be used safely and effectively in a range of doses to simultaneously treat a spectrum of upper facial rhytids in adult women, although use of a higher dose affords benefits for improved magnitude and durability of response without compromising safety, according to the results of a dose-comparison study presented by Alastair Carruthers, M.D., and Jean Carruthers, M.D., at the 63rd Annual Meeting of the American Academy of Dermatology (AAD).













